|
US3700612A
(en)
|
1971-06-23 |
1972-10-24 |
Tenneco Chem |
Aqueous surface-coating compositions containing hydroxyalkyl ethers of galactomannan gums as thickeners
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8422653D0
(en)
|
1984-09-07 |
1984-10-10 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5370872A
(en)
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
|
NZ249704A
(en)
|
1992-02-11 |
1996-11-26 |
Jackson H M Found Military Med |
A two carrier immunogenic construct comprising a 70+ kd molecule conjugated to at least 1 t-dependent antigen, preparation, compositions containing the construct
|
|
SK279188B6
(sk)
|
1992-06-25 |
1998-07-08 |
Smithkline Beecham Biologicals S.A. |
Vakcínová kompozícia spôsob jej prípravy a použiti
|
|
PT616034E
(pt)
|
1993-03-05 |
2005-02-28 |
Wyeth Corp |
Plasmideo para a producao de proteina crm e toxina da difteria
|
|
ES2210262T3
(es)
|
1993-09-22 |
2004-07-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Procedimiento que permite activar un glucido soluble con la ayuda de nuevos reactivos cianilantes para producir estructuras inmunogenas.
|
|
AUPM399594A0
(en)
|
1994-02-21 |
1994-03-17 |
Csl Limited |
Antigenic preparation for treatment or prevention of helicobacter infection
|
|
FI102976B
(fi)
|
1994-02-28 |
1999-03-31 |
Valtion Teknillinen |
Menetelmä lisäkeittokemikaalien tuottamiseksi sekä käyttämiseksi sulfa attiselluloosaprosessissa
|
|
WO1996029094A1
(en)
|
1995-03-22 |
1996-09-26 |
Andrew Lees |
Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
TR199902437T2
(xx)
|
1997-04-01 |
2000-01-21 |
Corixa Corporation |
Monofosforil lipid A'ya ait sulu im�nolojik adjuvant terkipleri.
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
US6858211B1
(en)
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
DK1126876T3
(da)
|
1998-10-16 |
2007-07-02 |
Glaxosmithkline Biolog Sa |
Adjuvanssystemer og vacciner
|
|
AU5162201A
(en)
|
2000-04-13 |
2001-10-30 |
Corixa Corporation |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
|
AU2001253568A1
(en)
|
2000-04-18 |
2001-10-30 |
Dan C. Deborde |
Lipopolysaccharide-conjugate vaccine for sepsis treatment
|
|
RU2189253C1
(ru)
|
2001-04-09 |
2002-09-20 |
Государственный научный центр прикладной микробиологии |
Диагностикум для идентификации escherichia coli o157 : h7 и способ его получения
|
|
US6676958B2
(en)
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
US20040110226A1
(en)
|
2002-03-01 |
2004-06-10 |
Xencor |
Antibody optimization
|
|
IL163806A0
(en)
|
2002-03-07 |
2005-12-18 |
Eidgenoess Tech Hochschule |
System and method for the production of recombinant glycosylated proteins in a prokaryotic host
|
|
AU2003901008A0
(en)
|
2003-03-04 |
2003-03-20 |
Anadis Ltd |
Composition for the treatment and prevention of bacterial infections
|
|
CN1324134C
(zh)
|
2003-12-22 |
2007-07-04 |
南开大学 |
对大肠杆菌o81型的o－抗原特异的核苷酸
|
|
WO2005095450A2
(en)
|
2004-03-30 |
2005-10-13 |
Nsgene A/S |
Therapeutic use of a growth factor, nsg33
|
|
CN101360831B
(zh)
|
2005-05-11 |
2013-07-10 |
Eth苏黎世公司 |
来自原核细胞的重组n-糖基化蛋白
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US8063063B2
(en)
|
2006-03-23 |
2011-11-22 |
Novartis Ag |
Immunopotentiating compounds
|
|
ES2536426T3
(es)
|
2006-03-23 |
2015-05-25 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores
|
|
JP4791866B2
(ja)
|
2006-03-24 |
2011-10-12 |
国立大学法人秋田大学 |
下痢原性大腸菌感染症の判別に用いられる固相等
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
EP2193146B1
(en)
|
2007-09-14 |
2016-05-25 |
Adimab, LLC |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
EP2242505A4
(en)
|
2008-01-08 |
2012-03-07 |
Biogenerix Ag |
GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
|
|
SG10201400320TA
(en)
|
2008-02-20 |
2014-05-29 |
Glycovaxyn Ag |
Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
|
|
EP3461840A1
(en)
|
2009-04-27 |
2019-04-03 |
Immuron Limited |
Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis
|
|
BRPI1011072B1
(pt)
|
2009-06-05 |
2021-09-28 |
Infectious Disease Research Institute |
Composto de gla, composições de vacina e farmacêutica compreendendo dito composto, bem como uso dos mesmos para estimular, induzir ou acentuar uma resposta imune em um indivíduo
|
|
WO2011062615A1
(en)
|
2009-11-19 |
2011-05-26 |
Glycovaxyn Ag |
Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
|
|
AU2011279073B2
(en)
|
2010-07-16 |
2016-06-09 |
Adimab, Llc |
Antibody libraries
|
|
JP2014502595A
(ja)
|
2010-12-10 |
2014-02-03 |
メルク・シャープ・アンド・ドーム・コーポレーション |
免疫原性組成物の撹拌誘導凝集を緩和する新規な製剤
|
|
CA2847621A1
(en)
|
2011-09-06 |
2013-03-14 |
Glycovaxyn Ag |
Bioconjugate vaccines made in prokaryotic cells
|
|
US9932598B2
(en)
|
2012-08-02 |
2018-04-03 |
The Regents Of The University Of California |
Metabolic engineering of microbial organisms
|
|
MY167579A
(en)
|
2012-08-16 |
2018-09-20 |
Pfizer |
Glycoconjugation processes and compositions
|
|
HK1212249A1
(en)
|
2012-09-10 |
2016-06-10 |
Glycovaxyn Ag |
Bioconjugates comprising modified antigens and uses thereof
|
|
EP2906681B1
(en)
|
2012-10-12 |
2019-01-09 |
GlaxoSmithKline Biologicals S.A. |
Methods of host cell modification
|
|
ES2713166T3
(es)
|
2012-11-07 |
2019-05-20 |
Glaxosmithkline Biologicals Sa |
Producción de vacuna recombinante en E. coli mediante conjugación enzimática
|
|
PT3363806T
(pt)
|
2012-12-20 |
2022-12-16 |
Pfizer |
Processo de glicoconjugação
|
|
EP2938363B1
(en)
|
2012-12-27 |
2019-08-21 |
GlaxoSmithKline Biologicals S.A. |
Methods and compositions relating to crm197
|
|
IL273685B2
(en)
|
2013-01-17 |
2023-10-01 |
X4 Pharmaceuticals Austria Gmbh |
Immunogens and vaccines containing O25b antigens
|
|
HUE046942T2
(hu)
|
2013-05-18 |
2020-04-28 |
Aduro Biotech Inc |
Készítmények és eljárások "Interferongén-stimulátor"-tól függõ jelátvitel aktiválására
|
|
CN103495161B
(zh)
|
2013-10-08 |
2019-06-18 |
江苏康泰生物医学技术有限公司 |
一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法
|
|
BR112016007727A8
(pt)
|
2013-10-11 |
2018-01-30 |
Glycovaxyn Ag |
célula hospedeira, e, método para produzir uma proteína n-glicosilada.
|
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
|
JP2016540764A
(ja)
|
2013-12-04 |
2016-12-28 |
グリコヴァキシン アーゲー |
大腸菌で合成された糖タンパク質ワクチンによる黄色ブドウ球菌感染の予防
|
|
CA2935532A1
(en)
|
2014-02-06 |
2015-08-13 |
Arsanis Biosciences Gmbh |
E. coli specific antibody sequences
|
|
LT3110441T
(lt)
*
|
2014-02-24 |
2024-04-25 |
Glaxosmithkline Biologicals S.A. |
Naujas polisacharidas ir jo panaudojimas
|
|
LT3131577T
(lt)
|
2014-04-17 |
2020-07-27 |
Glaxosmithkline Biologicals S.A. |
Modifikuotos ląstelės-šeimininkės ir jų naudojimas
|
|
CN105695497B
(zh)
|
2014-11-27 |
2019-09-24 |
中国人民解放军军事医学科学院生物工程研究所 |
一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
|
|
HUE057726T2
(hu)
|
2014-12-30 |
2022-06-28 |
Glaxosmithkline Biologicals Sa |
Fehérje glikozilálására szolgáló készítmények és módszerek
|
|
TWI715617B
(zh)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
|
|
GB201518668D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Immunogenic Comosition
|
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
|
AR109621A1
(es)
|
2016-10-24 |
2018-12-26 |
Janssen Pharmaceuticals Inc |
Formulaciones de vacunas contra glucoconjugados de expec
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
JP7551618B2
(ja)
|
2018-12-12 |
2024-09-17 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Ｏ－結合型グリコシル化のための修飾キャリアタンパク質
|
|
IL286467B1
(en)
*
|
2019-03-18 |
2025-10-01 |
Janssen Pharmaceuticals Inc |
Methods for producing bioconjugates of E. COLI O-antigen polysaccharides, preparations thereof and methods for using them
|
|
UY38616A
(es)
|
2019-03-18 |
2020-09-30 |
Janssen Pharmaceuticals Inc |
Bioconjugados de polisacáridos del antígeno-o de e. coli y métodos de producción y de uso de los mismos.
|
|
FR3098334B1
(fr)
|
2019-07-05 |
2021-07-23 |
Airbus Operations Sas |
Procédé et système de surveillance d’un état de conscience d’un opérateur dans un poste de pilotage d’un aéronef
|
|
IL307247A
(en)
*
|
2021-04-01 |
2023-11-01 |
Janssen Pharmaceuticals Inc |
Production of E. Coli O18 bioconjugates
|